|
Advertise
| Editorial | Print |
Audience | Website |
Webcasts |
E-Newsletters | Events
| Contacts
| Pharma DD, reports on important technical and business strategy issues from discovery through development and into commercialization. Delivered through feature articles, news, commentaries, case studies, and business statistics, CHI’s
Pharma DD will provide timely analysis and solutions, with emphasis on enduser perspective – making it a unique “must-read” for researchers and management in today’s life sciences.
Every-Issue Topic Areas Include:
- Discovery Biology
- Molecular Diagnostics and Biomarkers
- Recombinant Proteins, Antibodies, and Other Biologicals
- Chemistry and Drug Delivery
- Scientific, Technical, and Business Strategy
- Clinical Trials, Regulatory Issues and Post Approval Drug Safety
- Market Developments
|
|
Editorial
Editor-in-Chief
Malorye Branca
editor@pharmadd.com
Branca has extensive experience in the pharmaceutical, biotech and genomics fields through her role as the VP of publications at Cambridge Healthtech Institute, as well as senior informatics editor at Bio-IT World - where her 2003 series, "The New, New Pharmacogenomics," garnered her a Neal and ASBPE Gold award.
In addition, she was formerly vice president and director of Decision Resources’ Spectrum Life Sciences unit, where she launched the drug discovery and development portfolio
|
